Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress
Clinical trial NCT04903327 · TERMINATED
Trial details
- NCT number
- NCT04903327
- Sponsor
- Sorrento Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2022-08-29
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.